{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:39:47Z","timestamp":1793741987967,"version":"4.6.1"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-020-00280-9","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T12:05:04Z","timestamp":1600689904000},"page":"1001-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":477,"title":["Metabolic and epigenetic regulation of T-cell exhaustion"],"prefix":"10.1038","volume":"2","author":[{"given":"Fabien","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-3118","authenticated-orcid":false,"given":"Alison","family":"Jaccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-2882","authenticated-orcid":false,"given":"Pedro","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-3502","authenticated-orcid":false,"given":"Yi-Ru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-3774","authenticated-orcid":false,"given":"Ping-Chih","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"280_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 (2013).","journal-title":"Cell"},{"key":"280_CR2","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho, P. C. et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162, 1217\u20131228 (2015). Refs. 1 and 2 demonstrate that glucose deprivation suppresses T-cell antitumour immunity, which can be enhanced by metabolic reprogramming.","journal-title":"Cell"},{"key":"280_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman, N. M., Boothby, M. R. & Chi, H. Metabolic coordination of T cell quiescence and activation. Nat. Rev. Immunol. 20, 55\u201370 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"280_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1096\/fj.03-1001fje","volume":"18","author":"DE Bauer","year":"2004","unstructured":"Bauer, D. E. et al. Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J. 18, 1303\u20131305 (2004).","journal-title":"FASEB J."},{"key":"280_CR5","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","volume":"342","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).","journal-title":"Science"},{"key":"280_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749\u2013761 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"280_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68\u201378 (2012).","journal-title":"Immunity"},{"key":"280_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck, M. D. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166, 63\u201376 (2016).","journal-title":"Cell"},{"key":"280_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570\u2013586 (2017).","journal-title":"Cell"},{"key":"280_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.molmed.2017.07.006","volume":"23","author":"F Alfei","year":"2017","unstructured":"Alfei, F. & Zehn, D. T cell exhaustion: an epigenetically imprinted phenotypic and functional makeover. Trends Mol. Med. 23, 769\u2013771 (2017). This article demonstrates that TOX is a critical transcription factor in the development and maintenance of exhausted T cells during chronic viral infection.","journal-title":"Trends Mol. Med."},{"key":"280_CR11","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1172\/JCI46102","volume":"121","author":"L Baitsch","year":"2011","unstructured":"Baitsch, L. et al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350\u20132360 (2011).","journal-title":"J. Clin. Invest."},{"key":"280_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20142237","volume":"212","author":"PM Odorizzi","year":"2015","unstructured":"Odorizzi, P. M., Pauken, K. E., Paley, M. A., Sharpe, A. & Wherry, E. J. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J. Exp. Med. 212, 1125\u20131137 (2015).","journal-title":"J. Exp. Med."},{"key":"280_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. Science 354, 1165\u20131169 (2016).","journal-title":"Science"},{"key":"280_CR14","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"280_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","volume":"170","author":"HE Ghoneim","year":"2017","unstructured":"Ghoneim, H. E. et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell 170, 142\u2013157.e119 (2017). This article reveals that terminally exhausted T cells display a unique epigenetic landscape, which dampens T-cell effector functions and the efficacy of PD-1 blockade treatment.","journal-title":"Cell"},{"key":"280_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","volume":"45","author":"B Bengsch","year":"2016","unstructured":"Bengsch, B. et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion council. Immunity 45, 358\u2013373 (2016).","journal-title":"Immunity"},{"key":"280_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","volume":"16","author":"A Schurich","year":"2016","unstructured":"Schurich, A. et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep. 16, 1243\u20131252 (2016).","journal-title":"Cell Rep."},{"key":"280_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nm.4275","volume":"23","author":"P Fisicaro","year":"2017","unstructured":"Fisicaro, P. et al. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nat. Med. 23, 327\u2013336 (2017).","journal-title":"Nat. Med."},{"key":"280_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4049\/jimmunol.1701041","volume":"200","author":"A Sugiura","year":"2018","unstructured":"Sugiura, A. & Rathmell, J. C. Metabolic barriers to T cell function in tumors. J. Immunol. 200, 400\u2013407 (2018).","journal-title":"J. Immunol."},{"key":"280_CR20","doi-asserted-by":"publisher","first-page":"e93411","DOI":"10.1172\/jci.insight.93411","volume":"2","author":"PJ Siska","year":"2017","unstructured":"Siska, P. J. et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2, e93411 (2017).","journal-title":"JCI Insight"},{"key":"280_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.immuni.2016.08.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 701\u2013703 (2016). This article provides evidence of the link between dysfunctional mitochondria and decreased antitumour immunity.","journal-title":"Immunity"},{"key":"280_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma, X. et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab. 30, 143\u2013156.e145 (2019). This article shows that the ER-stress\u2013XBP1 pathway drives T-cell exhaustion via cholesterol in the tumour microenvironment.","journal-title":"Cell Metab."},{"key":"280_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09263-1","volume":"10","author":"Y Cao","year":"2019","unstructured":"Cao, Y. et al. ER stress-induced mediator C\/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat. Commun. 10, 1280 (2019).","journal-title":"Nat. Commun."},{"key":"280_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"280_CR25","doi-asserted-by":"publisher","first-page":"8623","DOI":"10.1073\/pnas.0809818106","volume":"106","author":"SN Mueller","year":"2009","unstructured":"Mueller, S. N. & Ahmed, R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl Acad. Sci. USA 106, 8623\u20138628 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"280_CR26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1084\/jem.20150598","volume":"213","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival. J. Exp. Med. 213, 1819\u20131834 (2016).","journal-title":"J. Exp. Med."},{"key":"280_CR27","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1128\/JVI.00889-12","volume":"86","author":"JM Angelosanto","year":"2012","unstructured":"Angelosanto, J. M., Blackburn, S. D., Crawford, A. & Wherry, E. J. Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. J. Virol. 86, 8161\u20138170 (2012).","journal-title":"J. Virol."},{"key":"280_CR28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","volume":"20","author":"DV Sawant","year":"2019","unstructured":"Sawant, D. V. et al. Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion. Nat. Immunol. 20, 724\u2013735 (2019).","journal-title":"Nat. Immunol."},{"key":"280_CR29","doi-asserted-by":"publisher","first-page":"8056","DOI":"10.1128\/jvi.68.12.8056-8063.1994","volume":"68","author":"M Matloubian","year":"1994","unstructured":"Matloubian, M., Concepcion, R. J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056\u20138063 (1994).","journal-title":"J. Virol."},{"key":"280_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"280_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe, A. H., Wherry, E. J., Ahmed, R. & Freeman, G. J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8, 239\u2013245 (2007).","journal-title":"Nat. Immunol."},{"key":"280_CR32","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485\u20132499 (2012).","journal-title":"J. Exp. Med."},{"key":"280_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.it.2017.05.008","volume":"38","author":"C Wang","year":"2017","unstructured":"Wang, C., Singer, M. & Anderson, A. C. Molecular dissection of CD8+ T-cell dysfunction. Trends Immunol. 38, 567\u2013576 (2017).","journal-title":"Trends Immunol."},{"key":"280_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452\u2013456 (2017).","journal-title":"Nature"},{"key":"280_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"280_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.2606","volume":"14","author":"DT Utzschneider","year":"2013","unstructured":"Utzschneider, D. T. et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat. Immunol. 14, 603\u2013610 (2013).","journal-title":"Nat. Immunol."},{"key":"280_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"280_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"280_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211.e110 (2019).","journal-title":"Immunity"},{"key":"280_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019). This article identifies a TCF1+ subpopulation of exhausted CD8+ TILs, denoted progenitor exhausted T cells, which are better able to control tumour growth with polyfunctionality and respond to anti-PD-1 treatment.","journal-title":"Nat. Immunol."},{"key":"280_CR41","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors. J. Exp. Med. 215, 2520\u20132535 (2018).","journal-title":"J. Exp. Med."},{"key":"280_CR42","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840\u2013855.e845 (2019).","journal-title":"Immunity"},{"key":"280_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841.e828 (2020).","journal-title":"Immunity"},{"key":"280_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566\u2013569 (2007).","journal-title":"Nature"},{"key":"280_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","volume":"27","author":"H Nishikawa","year":"2014","unstructured":"Nishikawa, H. & Sakaguchi, S. Regulatory T cells in cancer immunotherapy. Curr. Opin. Immunol. 27, 1\u20137 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"280_CR46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.trecan.2017.06.005","volume":"3","author":"H Wang","year":"2017","unstructured":"Wang, H., Franco, F. & Ho, P. C. Metabolic regulation of tregs in cancer: opportunities for immunotherapy. Trends Cancer 3, 583\u2013592 (2017).","journal-title":"Trends Cancer"},{"key":"280_CR47","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates, G. J. et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 24, 5373\u20135380 (2006).","journal-title":"J. Clin. Oncol."},{"key":"280_CR48","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.4049\/jimmunol.1002650","volume":"187","author":"YJ Kim","year":"2011","unstructured":"Kim, Y. J., Park, S. J. & Broxmeyer, H. E. Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction. J. Immunol. 187, 2291\u20132301 (2011).","journal-title":"J. Immunol."},{"key":"280_CR49","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","volume":"129","author":"JS Yi","year":"2010","unstructured":"Yi, J. S., Cox, M. A. & Zajac, A. J. T-cell exhaustion: characteristics, causes and conversion. Immunology 129, 474\u2013481 (2010).","journal-title":"Immunology"},{"key":"280_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40425-016-0109-1","volume":"4","author":"PC Ho","year":"2016","unstructured":"Ho, P. C. & Liu, P. S. Metabolic communication in tumors: a new layer of immunoregulation for immune evasion. J. Immunother. Cancer 4, 4 (2016).","journal-title":"J. Immunother. Cancer"},{"key":"280_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li, X. et al. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat. Rev. Clin. Oncol. 16, 425\u2013441 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"280_CR52","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"280_CR53","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","volume":"185","author":"Y Yan","year":"2010","unstructured":"Yan, Y. et al. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J. Immunol. 185, 5953\u20135961 (2010).","journal-title":"J. Immunol."},{"key":"280_CR54","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","volume":"69","author":"PC Rodriguez","year":"2009","unstructured":"Rodriguez, P. C. et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69, 1553\u20131560 (2009).","journal-title":"Cancer Res."},{"key":"280_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri.2016.80","volume":"16","author":"DE Speiser","year":"2016","unstructured":"Speiser, D. E., Ho, P. C. & Verdeil, G. Regulatory circuits of T cell function in cancer. Nat. Rev. Immunol. 16, 599\u2013611 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"280_CR56","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","volume":"22","author":"DH Munn","year":"2005","unstructured":"Munn, D. H. et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22, 633\u2013642 (2005).","journal-title":"Immunity"},{"key":"280_CR57","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4161\/onci.21716","volume":"1","author":"R Metz","year":"2012","unstructured":"Metz, R. et al. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: a novel IDO effector pathway targeted by D-1-methyl-tryptophan. OncoImmunology 1, 1460\u20131468 (2012).","journal-title":"OncoImmunology"},{"key":"280_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203 (2011).","journal-title":"Nature"},{"key":"280_CR59","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1084\/jem.20072076","volume":"205","author":"A Das","year":"2008","unstructured":"Das, A. et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205, 2111\u20132124 (2008).","journal-title":"J. Exp. Med."},{"key":"280_CR60","doi-asserted-by":"publisher","first-page":"e44210","DOI":"10.7554\/eLife.44210","volume":"8","author":"LV Sinclair","year":"2019","unstructured":"Sinclair, L. V. et al. Antigen receptor control of methionine metabolism in T cells. eLife 8, e44210 (2019).","journal-title":"eLife"},{"key":"280_CR61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmet.2016.12.011","volume":"25","author":"EH Ma","year":"2017","unstructured":"Ma, E. H. et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 25, 345\u2013357 (2017).","journal-title":"Cell Metab."},{"key":"280_CR62","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","volume":"41","author":"MM Staron","year":"2014","unstructured":"Staron, M. M. et al. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8+ T cells during chronic infection. Immunity 41, 802\u2013814 (2014).","journal-title":"Immunity"},{"key":"280_CR63","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s42255-019-0081-4","volume":"1","author":"M Angin","year":"2019","unstructured":"Angin, M. et al. Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat. Metab. 1, 704\u2013716 (2019).","journal-title":"Nat. Metab."},{"key":"280_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14137-7","volume":"11","author":"V Barili","year":"2020","unstructured":"Barili, V. et al. Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. Nat. Commun. 11, 604 (2020).","journal-title":"Nat. Commun."},{"key":"280_CR65","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1128\/MCB.01927-06","volume":"27","author":"ED MacKenzie","year":"2007","unstructured":"MacKenzie, E. D. et al. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell. Biol. 27, 3282\u20133289 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"280_CR66","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ni.2714","volume":"14","author":"AL Doedens","year":"2013","unstructured":"Doedens, A. L. et al. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 14, 1173\u20131182 (2013).","journal-title":"Nat. Immunol."},{"key":"280_CR67","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","volume":"32","author":"A Palazon","year":"2017","unstructured":"Palazon, A. et al. An HIF-1alpha\/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell 32, 669\u2013683.e665 (2017).","journal-title":"Cancer Cell"},{"key":"280_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","volume":"5","author":"NE Scharping","year":"2017","unstructured":"Scharping, N. E., Menk, A. V., Whetstone, R. D., Zeng, X. & Delgoffe, G. M. Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol. Res. 5, 9\u201316 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"280_CR69","doi-asserted-by":"publisher","first-page":"e124989","DOI":"10.1172\/jci.insight.124989","volume":"4","author":"YG Najjar","year":"2019","unstructured":"Najjar, Y. G. et al. Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight 4, e124989 (2019).","journal-title":"JCI Insight"},{"key":"280_CR70","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/eji.201445284","volume":"45","author":"R Vuillefroy de Silly","year":"2015","unstructured":"Vuillefroy de Silly, R. et al. Phenotypic switch of CD8+ T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur. J. Immunol. 45, 2263\u20132275 (2015).","journal-title":"Eur. J. Immunol."},{"key":"280_CR71","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer, K. et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109, 3812\u20133819 (2007).","journal-title":"Blood"},{"key":"280_CR72","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"280_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie, E., Schulze, A., Zechner, R., Walther, T. C. & Farese, R. V. Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153\u2013161 (2013).","journal-title":"Cell Metab."},{"key":"280_CR74","doi-asserted-by":"publisher","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","volume":"6","author":"AA Al-Khami","year":"2017","unstructured":"Al-Khami, A. A. et al. Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. OncoImmunology 6, e1344804 (2017).","journal-title":"OncoImmunology"},{"key":"280_CR75","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber, D. L. et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16, 880\u2013886 (2010).","journal-title":"Nat. Med."},{"key":"280_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00523-6","volume":"8","author":"Z Niu","year":"2017","unstructured":"Niu, Z. et al. Caspase-1 cleaves PPAR\u03b3 for potentiating the pro-tumor action of TAMs. Nat. Commun. 8, 766 (2017).","journal-title":"Nat. Commun."},{"key":"280_CR77","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","volume":"31","author":"CS Field","year":"2020","unstructured":"Field, C. S. et al. Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function. Cell Metab. 31, 422\u2013437.e425 (2020).","journal-title":"Cell Metab."},{"key":"280_CR78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"key":"280_CR79","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. et al. A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med. 24, 994\u20131004 (2018).","journal-title":"Nat. Med."},{"key":"280_CR80","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang, W. et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature 531, 651\u2013655 (2016).","journal-title":"Nature"},{"key":"280_CR81","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell 32, 377\u2013391.e379 (2017).","journal-title":"Cancer Cell"},{"key":"280_CR82","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature19364","volume":"537","author":"R Eil","year":"2016","unstructured":"Eil, R. et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 537, 539\u2013543 (2016).","journal-title":"Nature"},{"key":"280_CR83","doi-asserted-by":"publisher","first-page":"eaau0135","DOI":"10.1126\/science.aau0135","volume":"363","author":"SK Vodnala","year":"2019","unstructured":"Vodnala, S. K. et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 363, eaau0135 (2019).","journal-title":"Science"},{"key":"280_CR84","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","volume":"166","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell 166, 1500\u20131511.e1509 (2016).","journal-title":"Cell"},{"key":"280_CR85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","volume":"45","author":"A Schietinger","year":"2016","unstructured":"Schietinger, A. et al. Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis. Immunity 45, 389\u2013401 (2016).","journal-title":"Immunity"},{"key":"280_CR86","doi-asserted-by":"publisher","first-page":"E2776","DOI":"10.1073\/pnas.1620498114","volume":"114","author":"GP Mognol","year":"2017","unstructured":"Mognol, G. P. et al. Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells. Proc. Natl Acad. Sci. USA 114, E2776\u2013E2785 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"280_CR87","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","volume":"571","author":"F Alfei","year":"2019","unstructured":"Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265\u2013269 (2019).","journal-title":"Nature"},{"key":"280_CR88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"280_CR89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"280_CR90","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1073\/pnas.1905675116","volume":"116","author":"H Seo","year":"2019","unstructured":"Seo, H. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion. Proc. Natl Acad. Sci. USA 116, 12410\u201312415 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"280_CR91","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530\u2013534 (2019).","journal-title":"Nature"},{"key":"280_CR92","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","volume":"567","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567, 525\u2013529 (2019).","journal-title":"Nature"},{"key":"280_CR93","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature 576, 471\u2013476 (2019).","journal-title":"Nature"},{"key":"280_CR94","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.it.2018.01.005","volume":"39","author":"DG Franchina","year":"2018","unstructured":"Franchina, D. G., Dostert, C. & Brenner, D. Reactive oxygen species: involvement in T cell signaling and metabolism. Trends Immunol. 39, 489\u2013502 (2018).","journal-title":"Trends Immunol."},{"key":"280_CR95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"LA Sena","year":"2013","unstructured":"Sena, L. A. et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38, 225\u2013236 (2013).","journal-title":"Immunity"},{"key":"280_CR96","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature20165","volume":"540","author":"PA Tyrakis","year":"2016","unstructured":"Tyrakis, P. A. et al. S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature 540, 236\u2013241 (2016).","journal-title":"Nature"},{"key":"280_CR97","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","volume":"24","author":"L Bunse","year":"2018","unstructured":"Bunse, L. et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat. Med. 24, 1192\u20131203 (2018).","journal-title":"Nat. Med."},{"key":"280_CR98","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.immuni.2018.04.026","volume":"48","author":"B Bengsch","year":"2018","unstructured":"Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029\u20131045.e1025 (2018).","journal-title":"Immunity"},{"key":"280_CR99","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.brainres.2005.10.095","volume":"1077","author":"GA Larsen","year":"2006","unstructured":"Larsen, G. A., Skjellegrind, H. K., Berg-Johnsen, J., Moe, M. C. & Vinje, M. L. Depolarization of mitochondria in isolated CA1 neurons during hypoxia, glucose deprivation and glutamate excitotoxicity. Brain Res. 1077, 153\u2013160 (2006).","journal-title":"Brain Res."},{"key":"280_CR100","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1471-4159.2002.00827.x","volume":"81","author":"A Almeida","year":"2002","unstructured":"Almeida, A., Delgado-Esteban, M., Bola\u00f1os, J. P. & Medina, J. M. Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J. Neurochem. 81, 207\u2013217 (2002).","journal-title":"J. Neurochem."},{"key":"280_CR101","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/ijms20071792","volume":"20","author":"K Kemp","year":"2019","unstructured":"Kemp, K. & Poe, C. Stressed: the unfolded protein response in T cell development, activation, and function. Int. J. Mol. Sci. 20, 1792 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"280_CR102","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.4049\/jimmunol.181.8.5433","volume":"181","author":"D Kamimura","year":"2008","unstructured":"Kamimura, D. & Bevan, M. J. Endoplasmic reticulum stress regulator XBP-1 contributes to effector CD8+ T cell differentiation during acute infection. J. Immunol. 181, 5433\u20135441 (2008).","journal-title":"J. Immunol."},{"key":"280_CR103","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song, M. et al. IRE1\u03b1-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423\u2013428 (2018).","journal-title":"Nature"},{"key":"280_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis, N. et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6, 6692 (2015).","journal-title":"Nat. Commun."},{"key":"280_CR105","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40425-019-0628-7","volume":"7","author":"J Ogando","year":"2019","unstructured":"Ogando, J. et al. PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes. J. Immunother. Cancer 7, 151 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"280_CR106","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2019.08.013","volume":"51","author":"C Li","year":"2019","unstructured":"Li, C. et al. The transcription factor Bhlhe40 programs mitochondrial regulation of resident CD8+ T cell fitness and functionality. Immunity 51, 491\u2013507.e497 (2019).","journal-title":"Immunity"},{"key":"280_CR107","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","volume":"6","author":"PS Chowdhury","year":"2018","unstructured":"Chowdhury, P. S., Chamoto, K., Kumar, A. & Honjo, T. PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy. Cancer Immunol. Res. 6, 1375\u20131387 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"280_CR108","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.20171068","volume":"215","author":"AV Menk","year":"2018","unstructured":"Menk, A. V. et al. 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. J. Exp. Med. 215, 1091\u20131100 (2018).","journal-title":"J. Exp. Med."},{"key":"280_CR109","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/2326-6066.CIR-17-0767","volume":"6","author":"A Teijeira","year":"2018","unstructured":"Teijeira, A. et al. Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) costimulation. Cancer Immunol. Res. 6, 798\u2013811 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"280_CR110","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","volume":"29","author":"U Ozcan","year":"2008","unstructured":"Ozcan, U. et al. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol. Cell 29, 541\u2013551 (2008).","journal-title":"Mol. Cell"},{"key":"280_CR111","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1158\/2326-6066.CIR-18-0182","volume":"7","author":"KE Hurst","year":"2019","unstructured":"Hurst, K. E. et al. Endoplasmic reticulum stress contributes to mitochondrial exhaustion of CD8+ T cells. Cancer Immunol. Res. 7, 476\u2013486 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"280_CR112","first-page":"1000","volume":"41","author":"S Lee","year":"2018","unstructured":"Lee, S. & Min, K. T. The interface between ER and mitochondria: molecular compositions and functions. Mol. Cells 41, 1000\u20131007 (2018).","journal-title":"Mol. Cells"},{"key":"280_CR113","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/cells8091088","volume":"8","author":"D Namgaladze","year":"2019","unstructured":"Namgaladze, D., Khodzhaeva, V. & Br\u00fcne, B. ER-mitochondria communication in cells of the innate immune system. Cells 8, 1088 (2019).","journal-title":"Cells"},{"key":"280_CR114","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fcell.2019.00172","volume":"7","author":"O Moltedo","year":"2019","unstructured":"Moltedo, O., Remondelli, P. & Amodio, G. The mitochondria-endoplasmic reticulum contacts and their critical role in aging and age-associated diseases. Front. Cell Dev. Biol. 7, 172 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"280_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0237-7","volume":"9","author":"D Martinvalet","year":"2018","unstructured":"Martinvalet, D. The role of the mitochondria and the endoplasmic reticulum contact sites in the development of the immune responses. Cell Death Dis. 9, 336 (2018).","journal-title":"Cell Death Dis."},{"key":"280_CR116","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2018.02.012","volume":"48","author":"GR Bantug","year":"2018","unstructured":"Bantug, G. R. et al. Mitochondria-endoplasmic reticulum contact sites function as immunometabolic hubs that orchestrate the rapid recall response of memory CD8+ T cells. Immunity 48, 542\u2013555.e546 (2018). This article highlights the importance of mitochondria\u2013ER interaction in immunometabolic regulation and recall response in memory CD8 T cells.","journal-title":"Immunity"},{"key":"280_CR117","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259\u2013283 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"280_CR118","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fonc.2013.00292","volume":"3","author":"ML Boland","year":"2013","unstructured":"Boland, M. L., Chourasia, A. H. & Macleod, K. F. Mitochondrial dysfunction in cancer. Front. Oncol. 3, 292 (2013).","journal-title":"Front. Oncol."},{"key":"280_CR119","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2016.23","volume":"17","author":"PM Quir\u00f3s","year":"2016","unstructured":"Quir\u00f3s, P. M., Mottis, A. & Auwerx, J. Mitonuclear communication in homeostasis and stress. Nat. Rev. Mol. Cell Biol. 17, 213\u2013226 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"280_CR120","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tcb.2017.02.004","volume":"27","author":"O Matilainen","year":"2017","unstructured":"Matilainen, O., Quir\u00f3s, P. M. & Auwerx, J. Mitochondria and epigenetics: crosstalk in homeostasis and stress. Trends Cell Biol. 27, 453\u2013463 (2017).","journal-title":"Trends Cell Biol."},{"key":"280_CR121","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.aaf6284","volume":"354","author":"M Peng","year":"2016","unstructured":"Peng, M. et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481\u2013484 (2016).","journal-title":"Science"},{"key":"280_CR122","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.celrep.2019.04.022","volume":"27","author":"J Qiu","year":"2019","unstructured":"Qiu, J. et al. Acetate promotes T cell effector function during glucose restriction. Cell Rep. 27, 2063\u20132074.e2065 (2019).","journal-title":"Cell Rep."},{"key":"280_CR123","doi-asserted-by":"publisher","first-page":"14885","DOI":"10.1073\/pnas.1105133108","volume":"108","author":"S Kuroda","year":"2011","unstructured":"Kuroda, S. et al. Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression. Proc. Natl Acad. Sci. USA 108, 14885\u201314889 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"280_CR124","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/ni1473","volume":"8","author":"S Chang","year":"2007","unstructured":"Chang, S. & Aune, T. M. Dynamic changes in histone-methylation \u2018marks\u2019 across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat. Immunol. 8, 723\u2013731 (2007).","journal-title":"Nat. Immunol."},{"key":"280_CR125","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17\u201330 (2011).","journal-title":"Cancer Cell"},{"key":"280_CR126","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature19353","volume":"537","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli, M. et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537, 544\u2013547 (2016).","journal-title":"Nature"},{"key":"280_CR127","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature13981","volume":"518","author":"BW Carey","year":"2015","unstructured":"Carey, B. W., Finley, L. W., Cross, J. R., Allis, C. D. & Thompson, C. B. Intracellular \u03b1-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518, 413\u2013416 (2015).","journal-title":"Nature"},{"key":"280_CR128","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"280_CR129","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1111\/cas.13827","volume":"109","author":"S Nabe","year":"2018","unstructured":"Nabe, S. et al. Reinforce the antitumor activity of CD8+ T cells via glutamine restriction. Cancer Sci. 109, 3737\u20133750 (2018).","journal-title":"Cancer Sci."},{"key":"280_CR130","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"280_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05854-6","volume":"9","author":"J Suzuki","year":"2018","unstructured":"Suzuki, J. et al. The tumor suppressor menin prevents effector CD8 T-cell dysfunction by targeting mTORC1-dependent metabolic activation. Nat. Commun. 9, 3296 (2018).","journal-title":"Nat. Commun."},{"key":"280_CR132","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1126\/science.1226603","volume":"339","author":"N Shyh-Chang","year":"2013","unstructured":"Shyh-Chang, N. et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339, 222\u2013226 (2013).","journal-title":"Science"},{"key":"280_CR133","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.tem.2018.06.002","volume":"29","author":"C Ye","year":"2018","unstructured":"Ye, C. & Tu, B. P. Sink into the epigenome: histones as repositories that influence cellular metabolism. Trends Endocrinol. Metab. 29, 626\u2013637 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"280_CR134","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"280_CR135","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"280_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10501","volume":"7","author":"S Koyama","year":"2016","unstructured":"Koyama, S. et al. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat. Commun. 7, 10501 (2016).","journal-title":"Nat. Commun."},{"key":"280_CR137","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/modpathol.2017.89","volume":"30","author":"H Kakavand","year":"2017","unstructured":"Kakavand, H. et al. Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients. Mod. Pathol. 30, 1666\u20131676 (2017).","journal-title":"Mod. Pathol."},{"key":"280_CR138","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin, J. et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373, 23\u201334 (2015).","journal-title":"N. Engl. J. Med."},{"key":"280_CR139","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok, J. D. et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N. Engl. J. Med. 377, 1345\u20131356 (2017).","journal-title":"N. Engl. J. Med."},{"key":"280_CR140","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/1078-0432.CCR-15-1535","volume":"23","author":"JE Kim","year":"2017","unstructured":"Kim, J. E. et al. Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas. Clin. Cancer Res. 23, 124\u2013136 (2017).","journal-title":"Clin. Cancer Res."},{"key":"280_CR141","doi-asserted-by":"publisher","first-page":"e1448332","DOI":"10.1080\/2162402X.2018.1448332","volume":"7","author":"G Zhou","year":"2018","unstructured":"Zhou, G. et al. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. OncoImmunology 7, e1448332 (2018).","journal-title":"OncoImmunology"},{"key":"280_CR142","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44, 380\u2013390 (2016).","journal-title":"Immunity"},{"key":"280_CR143","doi-asserted-by":"publisher","first-page":"303ra139","DOI":"10.1126\/scitranslmed.aac5415","volume":"7","author":"DL Porter","year":"2015","unstructured":"Porter, D. L. et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci. Transl. Med. 7, 303ra139 (2015).","journal-title":"Sci. Transl. Med."},{"key":"280_CR144","first-page":"759","volume":"7","author":"D Alizadeh","year":"2019","unstructured":"Alizadeh, D. et al. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer. Immunol. Res. 7, 759\u2013772 (2019).","journal-title":"Immunol. Res."},{"key":"280_CR145","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2019.09.003","volume":"51","author":"EH Ma","year":"2019","unstructured":"Ma, E. H. et al. Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8+ T cells. Immunity 51, 856\u2013870.e855 (2019).","journal-title":"Immunity"},{"key":"280_CR146","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/mt.2014.91","volume":"22","author":"F Zhang","year":"2014","unstructured":"Zhang, F. et al. Epigenetic manipulation restores functions of defective CD8+ T cells from chronic viral infection. Mol. Ther. 22, 1698\u20131706 (2014).","journal-title":"Mol. Ther."},{"key":"280_CR147","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00262-019-02430-9","volume":"68","author":"TR McCaw","year":"2019","unstructured":"McCaw, T. R. et al. Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1. Cancer Immunol. Immunother. 68, 2081\u20132094 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"280_CR148","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-15-2584","volume":"22","author":"H Zheng","year":"2016","unstructured":"Zheng, H. et al. HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma. Clin. Cancer Res. 22, 4119\u20134132 (2016).","journal-title":"Clin. Cancer Res."},{"key":"280_CR149","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.immuni.2016.12.015","volume":"46","author":"TL Stephen","year":"2017","unstructured":"Stephen, T. L. et al. SATB1 expression governs epigenetic repression of PD-1 in tumor-reactive T cells. Immunity 46, 51\u201364 (2017).","journal-title":"Immunity"},{"key":"280_CR150","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307\u2013312 (2018).","journal-title":"Nature"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00280-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00280-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00280-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:14:46Z","timestamp":1670364886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-020-00280-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":150,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1038\/s42255-020-00280-9","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"30 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.-C.H. is serving as a scientific advisory board member for Elixiron Immunotherapeutics and Acepodia. P.-C.H. receives research grants from Roche and has received honoraria from Pfizer and Chugai. P.R. also receives research grants from Roche. The other authors have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}